Markets Businessinsider

Published September 23, 2026 · Updated September 24, 2026

Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications ...

Read the full story at Markets Businessinsider

(Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic -derived neuroplastogen for.